Cargando…
Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na(+)/K(+)-ATPase-density
PURPOSE: Tumour blood flow (TBF) is a crucial determinant of cancer growth. Recently, we validated Rubidium-82 ((82)Rb) positron emission tomography (PET) for TBF measurement in prostate cancer (PCa) and found TBF and cancer aggressiveness positively correlated. The aims of the present study were to...
Autores principales: | Jochumsen, Mads Ryø, Sörensen, Jens, Pedersen, Bodil Ginnerup, Nyengaard, Jens Randel, Krag, Søren Rasmus Palmelund, Frøkiær, Jørgen, Borre, Michael, Bouchelouche, Kirsten, Tolbod, Lars Poulsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835182/ https://www.ncbi.nlm.nih.gov/pubmed/32808078 http://dx.doi.org/10.1007/s00259-020-04998-2 |
Ejemplares similares
-
Repeatability of tumor blood flow quantification with (82)Rubidium PET/CT in prostate cancer — a test-retest study
por: Jochumsen, Mads Ryø, et al.
Publicado: (2019) -
Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness
por: Jochumsen, Mads Ryø, et al.
Publicado: (2021) -
Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by (68)Ga-PSMA PET/CT
por: Christensen, Mads T., et al.
Publicado: (2022) -
Rubidium-82 PET/CT in COVID-19
por: van de Burgt, Alina, et al.
Publicado: (2021) -
Perfusion imaging using rubidium-82 ((82)Rb) PET in rats with myocardial infarction: First small animal cardiac (82)Rb-PET
por: Clemmensen, Andreas Ettrup, et al.
Publicado: (2016)